DATE: 2010-07-30

Forbes		Wall Street Journal		Business Standard, India		Financial Times
Genzyme's Hidden Value By Matthew Herper		Senator Slams FDA Advisory Committee’s Avastin Decision By Alicia Mundy		Ranbaxy leads Japan's Daiichi Sankyo to profits By Reuters		Charles River calls off $1.6bn WuXi tie-up By Justine Lau

DATE: 2010-07-29

Forbes		New York Times		Wall Street Journal		BBC
The Sad Truth About $100,000 Cancer Drugs By Robert Langreth		A Novartis Giveaway of Medicine By Natasha Singer		Drug Firms Feel Pinch From Europe By Thomas Gryta		Hip hope from stem cell technique By Pallab Ghosh

DATE: 2010-07-28

Wall Street Journal, Health Blog		Forbes		NPR, Shots Health Blog		Boston Globe
A Reckoning for REMS: FDA’s Risk Program in the Spotlight By Katherine Hobson		Avandia's Exception By Anup Malani		Sanofi Files Suit To Block Sale Of Generic Lovenox By Scott Hensley		Champion for Haiti stresses local role By Stephen Smith

DATE: 2010-07-27

NPR		Wall Street Journal, Health Blog		New York Times, Op Ed		Financial Times
In Calif., Doctors Struggle To Provide Whooping Cough Vaccine By Whitney Blair Wyckoff		Study Finds Aggressive Treatment of Low-Risk Prostate Cancer By Katherine Hobson		Livesaving Medications, Through a Back Door By Abigail Zuger, M.D.		Brussels watchdog accuses Servier By Nikki Tait

DATE: 2010-07-26

Forbes		Wall Street Journal		NPR		New York Times
Novartis Exec: Golden Age Of Generic Biotech Drugs Is Coming By Robert Langreth		Genzyme Catches Eye of Others By Gina Chon, Anupreeta Das		Tiny Eye Telescope Brings Back A World Of Sight By Patti Neighmond		When a Drug Fails By Editorial

DATE: 2010-07-23

NPR, Shots Health Blog		Financial Times		BBC		Wall Street Journal
Genetic Testing Companies Busted By Undercover Patients By Allison Aubrey		Roche plays down US bar on cancer drug By Haig Simonian		Bone 'turnover' link to diabetes By Corrrespondent		Gene Shows Promise for Alzheimer's By Gautam Naik

DATE: 2010-07-22

The Guardian		Financial Times		New York Times		Forbes
GlaxoSmithKline makes £304m loss By Richard Wray		Roche sticks to full-year forecasts By Reuters		Glaxo Ordered to End Drug Trial Enrollment By Duff Wilson		The Cancer-Causing Sex Virus By Matthew Herper

DATE: 2010-07-21

Forbes		Wall Street Journal		Economic Times, Indiatimes		NPR, Fresh Air
Avastin Breast Cancer Vote Signals Tough Environment For Drug Companies By Robert Langreth		J&J’s 2010 Price Tag for Recalls: $600 Million. But What About Reputation? By Katherine Hobson		Glaxo takes new AIDS drug into final-stage tests By IST Agencies		Malaria: The 500,000-Year-Old 'Fever' That Won't Die By Sonia Shah

DATE: 2010-07-20

BBC		Wall Street Journal		Business Standard		Economic Times, Indiatimes
Scientists say vaginal gel cuts HIV-infections by half By Correspondent		New Test for Brain Injury on Horizon By Thomas M. Burton		Drug wholesellers form firm to foray into organised retail By Press Trust of India		Pharma cos oppose DCGI's ban on emergency contraceptive pill ads By Khomba Singh

DATE: 2010-07-19

The Guardian		Wall Street Journal, Health Blog		New York Times		Financial Times
Aids study says drugs used for treatment can reduce spread of disease By Sarah Boseley		Why One Stock Research Firm Won’t Cover Obesity Drugs By Katherine Hobson		Drug Trials Test Bold Plan to Slow Alzheimer’s By Gina Kolata		Watchdog given rebuke on drugs pacts probe By Stephanie Kirchgaessner

DATE: 2010-07-16

New York Times		The Guardian		NPR, Shots blog		Economic Times, Indiatimes
F.D.A. Panel Votes Against Obesity Drug By Andrew Pollack		Glaxo's settlement makes the dividend safer – probably By Nils Pratley		Health Law Makes Prevention Easier To Come By By Christopher Weaver		Sun Pharma gets USFDA nod for Flomax's generic version By IST Agencies

DATE: 2010-07-15

NPR		Forbes		New York Times		Wall Street Journal
The War On (Prescription) Drugs By Lee Hill		Health Experts Who May Decide Whether You Live Or Die By David Whelan		The Avandia Saga Continues By Editorial		Glaxo to Book £1.57 Billion Charge By Jeanne Whalen

ABOUT BETSY RAYMOND STEVENSON

Founder and Principal, RaymondStevenson Healthcare Communications (RSHC) >>>

ABOUT RSHC
Building Healthy Relationships

Expert and creative communications services for the pharmaceutical and biotechnology industries. >>>

• Strategic media relations
• Thought leader relations
• Integrated social media relations
• Media interview coaching
• Tactical support
• Issues management
• Global expertise
• Developing world expertise

PROFESSIONAL SOURCES